Active Biotech AB (FRA:BTP) E10: €-0.91 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:BTP Active Biotech AB FRA:BTP
30 GF Score
Price €0.41
GF Value €0.13
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Active Biotech AB E10?

Active Biotech AB FRA:BTP +0.86% 30 E10 is €-0.91 as of Jun. 2026. GuruFocus rates FRA:BTP with a GF Score™ of 30/100 and a GF Value™ of €0.13 (Significantly Overvalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Active Biotech AB's adjusted earnings per share data for the three months ended in Jun. 2026 was €-0.035. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.91 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was 26.70% per year. During the past 5 years, the average E10 Growth Rate was 18.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Active Biotech AB was 26.70% per year. The lowest was 8.50% per year. And the median was 12.50% per year.

As of today (2026-09-07), Active Biotech AB's current stock price is €0.4085. Active Biotech AB's E10 for the quarter that ended in Jun. 2026 was €-0.91. Active Biotech AB's Shiller PE Ratio of today is .


Active Biotech AB  (FRA:BTP) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Active Biotech AB E10 Related Terms


Active Biotech AB E10 Historical Data

* Premium members only.

The historical data trend for Active Biotech AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Active Biotech AB E10 Chart

Active Biotech AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.04 -3.70 -2.12 -2.62 -1.03

Active Biotech AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.19 0.00 -1.03 0.00 -0.91

FRA:BTP vs VRTX, REGN, MRNA: E10 Comparison

For the Biotechnology subindustry, Active Biotech AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Active Biotech AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's Shiller PE Ratio falls into.


FRA:BTP
30GF Score
Active Biotech AB FRA:BTP
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Active Biotech AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Active Biotech AB's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.035/134.6100*134.6100
=-0.035

Current CPI (Jun. 2026) = 134.6100.

Active Biotech AB Quarterly Data

per share eps CPI Adj_EPS
201609 -0.285 101.138 -0.379
201612 -0.301 102.022 -0.397
201703 -0.435 102.022 -0.574
201706 -0.532 102.752 -0.697
201709 -0.190 103.279 -0.248
201712 -1.280 103.793 -1.660
201803 -0.281 103.962 -0.364
201806 -0.177 104.875 -0.227
201809 -0.149 105.679 -0.190
201812 -0.152 105.912 -0.193
201903 -0.148 105.886 -0.188
201906 -0.098 106.742 -0.124
201909 -0.146 107.214 -0.183
201912 -0.312 107.766 -0.390
202003 -0.170 106.563 -0.215
202006 -0.177 107.498 -0.222
202009 -0.148 107.635 -0.185
202012 -0.061 108.296 -0.076
202103 -0.152 108.360 -0.189
202106 -0.183 108.928 -0.226
202109 -0.152 110.338 -0.185
202112 -0.239 112.486 -0.286
202203 -0.205 114.825 -0.240
202206 -0.204 118.384 -0.232
202209 -0.179 122.296 -0.197
202212 -0.176 126.365 -0.187
202303 -0.115 127.042 -0.122
202306 -0.110 129.407 -0.114
202309 -0.109 130.224 -0.113
202312 -0.128 131.912 -0.131
202403 -0.095 132.205 -0.097
202406 -0.095 132.716 -0.096
202409 -0.063 132.304 -0.064
202412 -0.138 132.987 -0.140
202503 -0.072 132.825 -0.073
202506 -0.083 133.699 -0.084
202509 0.000 133.480 0.000
202512 -0.092 133.390 -0.093
202603 0.000 133.560 0.000
202606 -0.035 134.610 -0.035

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.91 mean?
Active Biotech AB (FRA:BTP) has a E10 of €-0.91 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Active Biotech AB and its competitors.
Is Active Biotech AB's E10 too high?
Active Biotech AB's current E10 is €-0.91. Overall, Active Biotech AB has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Active Biotech AB's E10 compare to VRTX and REGN?
Active Biotech AB's E10 of €-0.91 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Active Biotech AB and its competitors. Active Biotech AB's current E10 is €-0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Active Biotech AB stock overvalued right now?
Based on GuruFocus' analysis, Active Biotech AB (FRA:BTP) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.13, compared to a current price of €0.41 — trading 214.2% above its estimated fair value. The current E10 is €-0.91. Active Biotech AB's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Active Biotech AB (FRA:BTP), the current E10 is €-0.91 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Active Biotech AB (FRA:BTP) Overvalued in 2026?

Based on GuruFocus' analysis, Active Biotech AB stock appears to be overvalued. The current stock price of €0.41 is trading 214.2% above its estimated GF Value™ of €0.13. GuruFocus considers Active Biotech AB to be Significantly Overvalued.

Key valuation signals for FRA:BTP:

  • E10: €-0.91
  • GF Value™: €0.13 vs. price of €0.41 (214.2% above fair value)
  • GF Score™: 30/100 with 1 warning sign

No single metric tells the full story. See the FRA:BTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Active Biotech AB Business Description

Other Exchanges ACTI:Sweden0GQU:UK
Address Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
30GF Score

Get the complete analysis for FRA:BTP

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.41
Price
€0.13
GF Value